期刊文献+

c-erb-B2在早期胃癌术后复发预测中的作用 被引量:2

The role of c-erb-B2 in predicting postoperative recurrence of early gastric cancer
下载PDF
导出
摘要 目的探讨c-erb-B2在早期胃癌术后复发预测中的作用。方法收集178例早期胃癌术后患者的手术切除石蜡组织标本。所有患者均进行了随访,采用计算机断层扫描(CT)、内窥镜活检、正电子发射断层成像(PET)-CT评估早期胃癌的复发情况。采用免疫组织化学染色(IHC)和荧光原位杂交(FISH)技术分别检测cerb-B2蛋白的表达情况和c-erb-B2基因的扩增状态。结果178例早期胃癌术后患者的复发率为7.87%(14/178)。不同性别、肿瘤浸润深度、淋巴结转移情况的早期胃癌术后患者的复发情况比较,差异均有统计学意义(P﹤0.05);不同年龄、分化情况、手术方式、肿瘤位置、肿瘤分型和肿瘤直径的早期胃癌术后患者的复发情况比较,差异均无统计学意义(P﹥0.05)。178例早期胃癌患者中,18例患者c-erb-B2阳性,包括复发患者12例和未复发患者6例。c-erb-B2阳性早期胃癌患者的复发率明显高于c-erb-B2阴性患者(P﹤0.01)。结论c-erb-B2阳性早期胃癌患者的复发率高,其可作为一种早期胃癌术后复发的预测分子标志物。 Objective To investigate the role of c-erb-B2 in predicting the postoperative recurrence of early gastric cancer(EGC).Method The paraffin embedded tissue specimens from 178 cases with EGC were collected during surgery.All patients were followed up regularly.Computed tomography(CT),endoscopy,and positron emission tomography(PET)-CT were used to evaluate the recurrence of EGC.Immunohistochemistry(IHC)and fluorescence in situ hybridization(FISH)were employed to detect c-erb-B2 protein expression and gene amplification.Result The recurrence rate of EGC was 7.87%(14/178)among the 178 cases with EGC after surgery.Sex,depth of tumor invasion and lymph node metastasis were related to the recurrence of EGC,with statistically significant differences noted(P<0.05);while age,degree of differentiation,surgical approach,tumor site,tumor subtype and tumor diameter were independent of EGC recurrence(P>0.05).Among the 178 cases of EGC,18 were with positive c-erb-B2,including 12 cases of recurrence and 6 without recurrence.Significantly higher recurrence rate was observed in c-erb-B2 positive patients compared to c-erb-B2 negative ones(P<0.01).Conclusion Positive expression of c-erb-B2 is associated with increased recurrence potential for EGC,thus may be employed as a predictive molecular biomarker for the recurrence of EGC.
作者 蔡志强 苏小岩 杨继元 CAI Zhiqiang;SU Xiaoyan;YANG Jiyuan(Department of Oncology,Jingzhou First People’s Hospital,Jingzhou 434000,Hubei,China)
出处 《癌症进展》 2020年第6期580-583,共4页 Oncology Progress
关键词 早期胃癌 复发 C-ERB-B2 预测 淋巴结转移 early gastric cancer recurrence c-erb-B2 prediction lymph node metastasis
  • 相关文献

参考文献1

二级参考文献21

  • 1Guan Zhen Yu,Ying Chen,Jie Jun Wang.Overexpression of Grb2/HER2 signaling in Chinese gastric cancer: their relationship with clinicopathological parameters and prognostic significance[J].Journal of Cancer Research and Clinical Oncology.2009(10)
  • 2Lindsey A. Torre,Freddie Bray,Rebecca L. Siegel,Jacques Ferlay,Joannie Lortet‐Tieulent,Ahmedin Jemal.Global cancer statistics, 2012[J]. CA: A Cancer Journal for Clinicians . 2015 (2)
  • 3Andreas H. Marx,Lars Tharun,Johanna Muth,Ana-Maria Dancau,Ronald Simon,Emre Yekebas,Jussuf T. Kaifi,Martina Mirlacher,Tim H. Brümmendorf,Carsten Bokemeyer,Jakob R. Izbicki,Guido Sauter.HER-2 amplification is highly homogenous in gastric cancer[J]. Human Pathology . 2009 (6)
  • 4HER2 diagnostics in gastric cancer—guideline validation and development of standardized immunohistochemical testing[J]. Virchows Archiv . 2010 (3)
  • 5Carol E. DeSantis,Chun Chieh Lin,Angela B. Mariotto,Rebecca L. Siegel,Kevin D. Stein,Joan L. Kramer,Rick Alteri,Anthony S. Robbins,Ahmedin Jemal.Cancer treatment and survivorship statistics, 2014[J]. CA: A Cancer Journal for Clinicians . 2014 (4)
  • 6I. García,F. Vizoso,A. Martín,L. Sanz,O. Abdel-Lah,P. Raigoso,J. L. García-Mu?iz.Clinical Significance of the Epidermal Growth Factor Receptor and HER2 Receptor in Resectable Gastric Cancer[J]. Annals of Surgical Oncology . 2003 (3)
  • 7Stephen B. Edge,Carolyn C. Compton.The American Joint Committee on Cancer: the 7th Edition of the AJCC Cancer Staging Manual and the Future of TNM[J]. Annals of Surgical Oncology . 2010 (6)
  • 8Tomonori Yano,Toshihiko Doi,Atsushi Ohtsu,Narikazu Boku,Kaoru Hashizume,Mamoru Nakanishi,Atsushi Ochiai.??Comparison of HER2 gene amplification assessed by fluorescence in situhybridization and HER2 protein expression assessed by immunohistochemistry ingastric cancer(J)Oncology Reports . 2006 (1)
  • 9Heike Grabsch,Shivan Sivakumar,Sally Gray,Helmut E. Gabbert,Wolfram Müller.??HER2 expression in gastric cancer: Rare, heterogeneous and of no prognostic value – conclusions from 924 cases of two independent series(J)Cellular Oncology . 2010 (1-2)
  • 10Dong Il Park,Jung Won Yun,Jung Ho Park,Suk Joong Oh,Hong Joo Kim,Yong Kyun Cho,Chong Il Sohn,Woo Kyu Jeon,Byung Ik Kim,Chang Hak Yoo,Byung Ho Son,Eun Yoon Cho,Seoung Wan Chae,Eo-Jin Kim,Jin Hee Sohn,Seung Ho Ryu,Antonia R. Sepulveda.??HER-2 / neu Amplification Is an Independent Prognostic Factor in Gastric Cancer(J)Digestive Diseases and Sciences . 2006 (8)

共引文献7

同被引文献25

引证文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部